DOXIUM

This brand name is authorized in Austria, Ecuador, Spain, France, Hong Kong, Mexico, Poland, Romania, Turkey

Active ingredients

The drug DOXIUM contains one active pharmaceutical ingredient (API):

1 Calcium dobesilate UNII 5921X1560Q - CALCIUM DOBESILATE

Calcium dobesilate is a regulator of capillary functions. Calcium dobesilate acts on the capillary walls by regulating its impaired physiological functions – increased permeability and decreased resistance. It increases erythrocyte flexibility, inhibits platelet hyperaggregation and, in diabetic retinopathy, it reduces plasma and blood hyperviscosity, thus improving blood rheological properties and tissue irrigation. Read about Calcium dobesilate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05BX01	Calcium dobesilate	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BX Other sclerosing agents
Discover more medicines within C05BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28610-10-08
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54553
Country: FR	Base de données publique des médicaments	Identifier(s): 64081901
Country: HK	Department of Health Drug Office	Identifier(s): 34950
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 012M80
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100122941
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68800001, W68800002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514091035, 8699514091042, 8699514154457, 8699514154464